✦ LIBER ✦

Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)

✍ Scribed by A. Oliver Sartor; John M. Fitzpatrick

Book ID: 115199428
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 437 KB
Volume: 110
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2011.10818.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN45 DIFFERENCES IN HEALTH-CARE COSTS F

PCN45 DIFFERENCES IN HEALTH-CARE COSTS FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC) TREATED BY ONCOLOGISTS OR UROLOGISTS

✍ NM Engel-Nitz; B Alemayehu; F Nathan; D Parry; M Kulakodlu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

7021 POSTER Multidisciplinary Management

7021 POSTER Multidisciplinary Management of Castration Resistant Prostate Cancer (CRPC) in France – a Survey Comparing Practices and Assessing Collaboration Between Urologists and Oncologists

✍ de La Motte Rouge, T.; Pouessel, D.; Benchikh, A.; Dubosq, F.; Durand, X.; Gilli 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

P110 The assessment of therapeutic pract

P110 The assessment of therapeutic practice of urologists and clinical oncologists and the pattern of referrals in the treatment of metastatic Castration-Resistant Prostate Cancer (mCRPC) in Poland (ProSTandard Registry)

✍ Skoneczna, I.; Zdrojowy, R.; Sosnowski, M.; Poborski, W.; Oczkowski, P.; Pusteln 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Prototype Model in Metastatic Castrate-R

Prototype Model in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): A Tool to Position New Treatments in the Patient Pathway?

✍ Karcher, H.; Dinet, J.; Amzal, B.; Marteau, F.; Obrzut, G.; Pieniazek, I.; Brula 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

A phase I study of combined docetaxel an

A phase I study of combined docetaxel and repeated high activity186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial)

✍ Joyce M. van Dodewaard-de Jong; John M. H. de Klerk; Haiko J. Bloemendal; Bart P 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 136 KB

710 DOSE FINDING AND EFFICACY PHASE 2 ST

710 DOSE FINDING AND EFFICACY PHASE 2 STUDY OF INECALCITOL, A NEW VDR AGONIST, IN COMBINATION WITH DOCETAXEL-PREDNISONE REGIMEN FOR CASTRATION-RESISTANT PROSTATE CANCER (CRPC) PATIENTS (PTS)

✍ Medioni, Jacques; Deplanque, Gael; Maurina, Tristan; Ferrero, Jean-Marc; Rodier, 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 150 KB